GeoVax to Present at BIO International Convention 2024 [Yahoo! Finance]
GeoVax Labs, Inc. (GOVX)
NASDAQ:AMEX Investor Relations:
geovax.com/contact-geovax.html
Company Research
Source: Yahoo! Finance
ATLANTA, GA - ( NewMediaWire ) - May 29, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at the BIO International Convention 2024 being held June 3-6 in San Diego. Details of the presentation are as follows: Date: June 3, 2024 Time: 3:45 p.m. Pacific Time Location: San Diego Convention Center, Company Presentation Theater 2 Format: Company Presentation & One-On-One Meetings Registration: Click Here During the conference, members of the GeoVax management team will host one-on-one meetings with registered attendees to explore collaborative and strategic opportunities around the company's development portfolio including GEO-CM04S1, a multi-antigenic, next generation COVID-19 vaccine currently being investigated in three Phase 2 studies and Gedeptin (R) , an adenovirus-vectored bacterial purine phosphorylase designed to loc
Show less
Read more
Impact Snapshot
Event Time:
GOVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GOVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GOVX alerts
High impacting GeoVax Labs, Inc. news events
Weekly update
A roundup of the hottest topics
GOVX
News
- GeoVax Labs, Inc. (NASDAQ: GOVX) had its price target raised by analysts at HC Wainwright from $8.00 to $120.00. They now have a "buy" rating on the stock.MarketBeat
- GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1 [Yahoo! Finance]Yahoo! Finance
- GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market [Yahoo! Finance]Yahoo! Finance
- GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineGlobeNewswire
GOVX
Earnings
- 11/8/23 - Miss
GOVX
Sec Filings
- 6/21/24 - Form 8-K
- 6/20/24 - Form EFFECT
- 6/18/24 - Form 8-K
- GOVX's page on the SEC website